Fennec Pharmaceuticals (FENC) Free Cash Flow Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.67% |
| Sep 30, 2025 | 17.86% |
| Jun 30, 2025 | -3.42% |
| Mar 31, 2025 | -2.87% |
| Dec 31, 2024 | 1.50% |
| Sep 30, 2024 | 0.26% |
| Jun 30, 2024 | -24.93% |
| Mar 31, 2024 | 76.34% |
| Dec 31, 2023 | -10.65% |
| Sep 30, 2023 | -11.54% |
| Jun 30, 2023 | -20.24% |
| Mar 31, 2023 | -26.42% |
| Dec 31, 2022 | -38.81% |
| Sep 30, 2022 | -39.22% |
| Jun 30, 2022 | -37.57% |
| Mar 31, 2022 | -33.44% |
| Dec 31, 2021 | -39.65% |
| Sep 30, 2021 | -40.31% |
| Jun 30, 2021 | -56.60% |
| Mar 31, 2021 | -48.41% |
| Dec 31, 2020 | -50.59% |
| Sep 30, 2020 | -60.65% |
| Jun 30, 2020 | -43.56% |
| Mar 31, 2020 | -55.08% |
| Dec 31, 2019 | -27.71% |
| Sep 30, 2019 | -38.22% |
| Jun 30, 2019 | -46.39% |
| Mar 31, 2019 | -45.67% |
| Dec 31, 2018 | -45.78% |
| Sep 30, 2018 | -27.80% |
| Jun 30, 2018 | -12.05% |
| Mar 31, 2018 | -33.52% |
| Dec 31, 2017 | -18.83% |
| Sep 30, 2017 | -5.70% |
| Jun 30, 2017 | 9.50% |
| Mar 31, 2017 | -3.15% |
| Dec 31, 2016 | 4.45% |
| Sep 30, 2016 | 3.08% |
| Jun 30, 2016 | -17.77% |
| Mar 31, 2016 | 13.79% |
| Dec 31, 2015 | 8.33% |
| Sep 30, 2015 | 1.54% |
| Jun 30, 2015 | -5.77% |